Unrelated donor umbilical cord blood transplantation for the treatment of hematologic malignancies Journal Article

   

Authors:	Sauter, C.; Barker, J. N.
Article Title:	Unrelated donor umbilical cord blood transplantation for the treatment of hematologic malignancies
Abstract:	URD umbilical cord blood is an alternative HSC source offering a unique set of advantages and disadvantages as compared with the transplantation of HSC from unrelated volunteers. Improved transplant outcomes are now making UCBT a rival to URD transplantation for the treatment of hematologic malignancies. © 2008 Wolters Kluwer Health|Lippincott Williams & Wilkins.
Keywords:	survival rate; fludarabine; clinical trial; mortality; review; outcome assessment; cyclophosphamide; hematopoietic stem cell transplantation; groups by age; cord blood; cord blood stem cell transplantation; engraftment; hematologic malignancy; hla matching; fetal blood; blood bank; hematologic neoplasms; tissue donors; graft versus host reaction; reduced intensity conditioning; transplantation conditioning; umbilical cord blood; intermethod comparison; methylprednisolone; hematopoietic stem cell; graft rejection; cyclosporin a; bone marrow transplantation; thymocyte antibody; hla system; infectious complication; allogeneic transplantation; blood donor; umbilical cord blood transplantation
Journal Title:	Current Opinion in Hematology
Volume:	15
Issue:	6
ISSN:	1065-6251
Publisher:	Lippincott Williams & Wilkins, Ltd.
Date Published:	2008-11-01
Start Page:	568
End Page:	575
Language:	English
DOI:	10.1097/MOH.0b013e3283136718
PUBMED:	18832927
PROVIDER:	scopus
PMCID:	PMC3705957
DOI/URL:	http://www.scopus.com/inward/record.url?eid=2-s2.0-55149100620&partnerID=40&md5=6f4fe7872584acdfe32c5686cf8ac073
Notes:	--- - "Cited By (since 1996): 15" - "Export Date: 17 November 2011" - "CODEN: COHEF" - "Source: Scopus"

https://synapse.mskcc.org/synapse/works/has_related_data_chk/15279